Punit Dhillon, BA
Punit is the co-founder and CEO of a leading biopharmaceutical company based in the U.S. that develops advanced-stage immunotherapy to treat solid tumors. Punit was formerly Vice President of Finance and Operations at Inovio Pharmaceuticals, Inc., where he raised over $160 million through multiple financings and several licensing transactions, including early stage deals with Merck and Wyeth. Punit’s management experience spans corporate finance, M&A integration, successful in-licensing of key intellectual property, strategy implementation, corporate transactions and collaborations with leading universities and key global opinion leaders. He is also the founder of BeCancerPositive.org, an online community for cancer patients.
In 2013 he was recognized as one of the “Top 100” CEOs by PharmaVoice and “Most Admired CEO” by the San Diego Business Journal. In 2014, he was recognized as a finalist for Ernst & Young’s “Entrepreneur of the Year”. Punit holds a BA (Honours) in Political Science and a minor in Business Administration from Simon Fraser University.